B. Besostri et al., Increased expression of non-functional killer inhibitory receptor CD94 in CD8(+) cells of myeloma patients, BR J HAEM, 109(1), 2000, pp. 46-53
Different MHC class I-specific killer inhibitory receptors (KIRs) are expre
ssed in vivo by a minor fraction of activated memory CD8(+) cells. It has b
een postulated that KIRs may 'fine-tune' specific responses by altering the
ir threshold of activation by the TCR-CD3 complex. We have previously shown
that, in multiple myeloma (MM) patients, a large fraction of peripheral bl
ood CD8(+) cells display the phenotype of chronically activated memory T ce
lls (CD38(+), HLA-DR+, CD25(-), CD45R0(+), CD28(-)). We investigated the ex
pression of KIRs on MM T cells and determined their possible influence on c
ytolytic responses elicited via the CD3-TCR complex. The expression of CD94
, a molecule that is part of a heterodimeric KIR recognizing the nonclassic
al MHC surface HLA-E molecule, was almost threefold higher in MM T cells th
an in age-matched normal control subjects (P < 0.0001). CD94 expression was
preferentially confined to CD8(+) cells but not restricted to activated (H
LA-DR+) and/or memory (CD45R0(+)) T cells. Unlike normal T cells, in which
CD94 is assembled with glycoproteins of the NKG2 family to form functional
receptors with activating or inhibitory properties, most CD94(+) MM T cells
were devoid of both the NKG2-A and NKG2-C glycoproteins detected in the in
hibitory or activating form respectively. CD94 blockade did not significant
ly affect either T-cell proliferation or cytotoxic T-lymphocyte generation
induced by the myeloma-derived cell lines NCI and RPMI 8226. Similarly, the
cytolytic activity induced by direct anti-CD3-mediated targeting of MM T c
ells to FCR+ P815 target cells was unaffected by the addition of anti-CD94
and/or anti-NKG2-A/C monoclonal antibodies (mAbs). These data indicate that
the large majority of MM CD8(+) cells do not express a functional CD94 rec
eptor. Thus, their ability to 'fine-tune' an appropriate immune response ag
ainst tumour cells can be impaired.